Clinical Trial Evidence for a CDK4/6 Inhibitor Combination Therapy Complemented by an Evaluation of Real-World Effectiveness

Pfizer, Inc.
September 7, 2021
 

Please join our speaker, Christine Helou, MSN, FNP-BC, OCN on Thursday, September 9, 2021, at 3:00–3:45 PM EDT for an informative promotional product theater sponsored by Pfizer!

Christine Helou, MSN, FNP-BC, OCN, is a board-certified family nurse practitioner at Virginia Cancer Specialists in Fairfax, VA. She started her career as an oncology certified nurse at Inova Fairfax Hospital in 2005. She joined Virginia Cancer Specialists in 2012, following her graduation from the collaborative nurse practitioner program offered jointly by George Mason University and George Washington University. Ms. Helou has served as a sub-investigator for the breast cancer PALOMA-2 and PALOMA-3 trials.

During this product theater, Christine Helou will present a promotional program on “Clinical Trial Evidence for a CDK4/6 Inhibitor Combination Therapy Complemented by an Evaluation of Real-World Effectiveness.”

 

A product theater sponsored by Pfizer Oncology.